Industry Roundup: Supplement GMPs, Walgreens Recall, Healthy Children Study, Homeopathic Comments, Drug Claims
This article was originally published in The Tan Sheet
Botanicals firm argues GMP intent; Walgreens multivitamin missing child-resistant capsWyeth Nutrition supports NIH healthy children study; homeopathic regulatory evaluation comment period extended; Vitamin Shoppe adds Beardall; and more news in brief.
You may also be interested in...
Non-compliant cap prompts GNC Women’s Iron recall; Pedialyte Sparking Rush takes on sports drinks; ALA, curcumin in latest HydroxyCut formulation; Australian ingrown hair treatments reach US; Canadian cardio health drinks reach US; Sankaran to lead PepsiCo in North America; and Peet’s Coffee invests adjacent kombucha market.
The industry wants FDA to consider that a fraction of poison control reports are for homeopathics compared to other drugs and the agency’s current enforcement authorities maintain compliance in manufacturing and marketing the products. FDA is considering whether to maintain its policy that recognizes an ingredient’s inclusion in the HPUS monograph as pre-market approval.
Major Chinese biopharma contract services group WuXi Biologics' share price plummeted after it said external factors would contribute to it missing original revenue targets this year in multiple areas.